PCSK9 VACCINE AND METHODS OF USING THE SAME
United Kingdom
15708062.3
Filed on 2015-02-11
15708062.3
Filed on 2015-02-11
PCSK9 VACCINE AND METHODS OF USING THE SAME
France
15708062.3
Filed on 2015-02-11
15708062.3
Filed on 2015-02-11
PCSK9 VACCINE AND METHODS OF USING THE SAME
Germany
15708062.3
Filed on 2015-02-11
15708062.3
Filed on 2015-02-11
PCSK9 VACCINE AND METHODS OF USING THE SAME
Switzerland
15708062.3
Filed on 2015-02-11
15708062.3
Filed on 2015-02-11
Methods for Subtyping Lymphoma Types by Means of Expression Profiling
Japan
2020-018323
Filed on 2020-02-05
2020-018323
Filed on 2020-02-05
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A VLP-REPLICON
European Patent
20150087.3
Filed on 2020-01-02
20150087.3
Filed on 2020-01-02
IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN
US Patent 11,795,235
Filed on 2020-03-18
Filed on 2020-03-18
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen
Japan
2020-018005
Filed on 2020-02-05
2020-018005
Filed on 2020-02-05
Optimal Dosing Of Heterodimeric Interleukin-15 (IL-15)
US Application 16/411,062
Filed on 2019-05-13
Filed on 2019-05-13